KARMANOS CANCER HOSPITAL — History
CCN 230297 | 3-year financial timeline | COVID resilience: 62/100
🛡️ Public data only — no PHI permitted on this instance.
$285M
Latest Revenue (FY2022)
+13.2%
Revenue CAGR (3yr)
-27.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $222M | $272M | $285M | +4.7% | +13.2% |
| Operating Expenses | $290M | $337M | $364M | +8.0% | +12.0% |
| Operating Margin | -30.6% | -23.9% | -27.8% | -16.0% | +0.0% |
| Net Income | $-68M | $-65M | $-79M | -21.5% | +0.0% |
| Licensed Beds | 123 | 123 | 106 | -13.8% | -7.2% |
| Total Patient Days | 22,908 | 23,612 | 20,973 | -11.2% | -4.3% |
| Medicare Day % | 26% | 21% | 21% | +1.8% | -9.1% |
| Medicaid Day % | 3% | 3% | 4% | +44.2% | +14.4% |
COVID Impact & Recovery
Resilience Score: 62/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +28.2% ($222M → $285M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+13.2%
This Hospital
+7.6%
State Avg
Latest Margin
-27.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $316M | -26.3% |
| FY2024 (proj) | $347M | -24.9% |
| FY2025 (proj) | $379M | -23.5% |